An open label, randomised controlled trial of rifapentine versus rifampicin based short course regimens for the treatment of latent tuberculosis in England: the HALT LTBI pilot study

Overview of attention for article published in BMC Infectious Diseases, January 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter: 6 X users

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 77 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 13,703 followers.

Open Access UCL Research: An open label, randomised controlled trial of rifapentine versus rifampicin based short course regimens for the treatment of latent tuberculosis in England: the HALT LTBI pilot study https://t.co/swYE7UHNQn

04 Feb 2021

Reply Repost Favourite

An open-label, randomised controlled trial of rifapentine versus rifampicin based short-course regimens for the treatment of latent tuberculosis in England: the HALT LTBI pilot study https://t.co/uDxJYMF708 https://t.co/yx2eIE7efn @BMC_series #BMCInfectDi

02 Feb 2021

Reply Repost Favourite

Very pleased to see this piece out- thank you @juliansurey

28 Jan 2021

Reply Repost Favourite

RT @tomayates: NEW PAPER: Great to see @juliansurey get this over the line! 3HP seems just as good as 3HR (both self administered) in small…

28 Jan 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.